NURO
NURO Real Time Price USDRecent trades of NURO by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by NURO's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$20,000 Jul 24, 2008 Issue: Health Issues
-
$20,000 Feb 14, 2008 Issue: Medicare/Medicaid
-
$20,000 Aug 14, 2007 Issue: Medicare/Medicaid
-
$40,000 Aug 03, 2007 Issue: Health Issues
Estimated quarterly lobbying spending
NURO Revenue by Segment or Geography
New patents grants
-
Patent Title: “smart” electrode assembly for transcutaneous electrical nerve stimulation (tens) Nov. 05, 2024
-
Patent Title: Intelligent determination of therapeutic stimulation intensity for transcutaneous electrical nerve stimulation Jan. 30, 2024
-
Patent Title: Apparatus and method for button-free control of a wearable transcutaneous electrical nerve stimulator using interactive gestures and other means Aug. 22, 2023
-
Patent Title: Apparatus and method for relieving pain using transcutaneous electrical nerve stimulation Aug. 08, 2023
-
Patent Title: Transcutaneous electrical nerve stimulation using novel unbalanced biphasic waveform and novel electrode arrangement Nov. 29, 2022
-
Patent Title: Transcutaneous electrical nerve stimulation (tens) device Jul. 19, 2022
-
Patent Title: Transcutaneous electrical nerve stimulator with automatic detection of leg orientation and leg motion for enhanced sleep analysis, including enhanced transcutaneous electrical nerve stimulation (tens) using the same Mar. 01, 2022
-
Patent Title: Transcutaneous electrical nerve stimulator with automatic detection of user sleep-wake state Feb. 15, 2022
-
Patent Title: Dynamic control of transcutaneous electrical nerve stimulation therapy using continuous sleep detection Feb. 15, 2022
-
Patent Title: “smart” electrode assembly for transcutaneous electrical nerve stimulation (tens) Feb. 01, 2022
-
Patent Title: Detecting cutaneous electrode peeling using electrode-skin impedance Dec. 07, 2021
-
Patent Title: Apparatus and method for the automated control of transcutaneous electrical nerve stimulation based on current and forecasted weather conditions Jul. 13, 2021
-
Patent Title: Apparatus and method for button-free control of a wearable transcutaneous electrical nerve stimulator using interactive gestures and other means Mar. 09, 2021
-
Patent Title: Apparatus and method for the automated measurement of sural nerve conduction velocity and amplitude Jan. 05, 2021
-
Patent Title: Transcutaneous electrical nerve stimulation using novel unbalanced biphasic waveform and novel electrode arrangement Dec. 15, 2020
-
Patent Title: Apparatus and method for relieving pain using transcutaneous electrical nerve stimulation Sep. 22, 2020
-
Patent Title: Transcutaneous electrical nerve stimulation device strap Nov. 05, 2019
-
Patent Title: Transcutaneous electrical nerve stimulation (tens) device Oct. 08, 2019
-
Patent Title: Apparatus for transcutaneous electrical nerve stimulation Oct. 01, 2019
-
Patent Title: Transcutaneous electrical nerve stimulation device Aug. 27, 2019
-
Patent Title: Apparatus and method for automated compensation of transcutaneous electrical nerve stimulation for temporal fluctuations such as circadian rhythms Aug. 20, 2019
-
Patent Title: Dynamic control of transcutaneous electrical nerve stimulation therapy using continuous sleep detection Jul. 02, 2019
-
Patent Title: Bioelectrode Jun. 11, 2019
-
Patent Title: Measuring the “on-skin” time of a transcutaneous electrical nerve stimulator (tens) device in order to minimize skin irritation due to excessive uninterrupted wearing of the same May. 21, 2019
-
Patent Title: Transcutaneous electrical nerve stimulator with automatic detection of user sleep-wake state May. 07, 2019
-
Patent Title: Transcutaneous electrical nerve stimulation (tens) device Jan. 01, 2019
-
Patent Title: Detecting cutaneous electrode peeling using electrode-skin impedance Dec. 25, 2018
-
Patent Title: Transcutaneous electrical nerve stimulator with user gesture detector and electrode-skin contact detector, with transient motion detector for increasing the accuracy of the same Nov. 20, 2018
-
Patent Title: Transcutaneous electrical nerve stimulation using novel unbalanced biphasic waveform and novel electrode arrangement Oct. 30, 2018
-
Patent Title: Apparatus and method for stimulator on-skin short detection Jun. 26, 2018
-
Patent Title: Transcutaneous electrical nerve stimulator with user gesture detector and electrode-skin contact detector, with transient motion detector for increasing the accuracy of the same Nov. 28, 2017
-
Patent Title: Transcutaneous electrical nerve stimulator with automatic detection of leg orientation and leg motion for enhanced sleep analysis, including enhanced transcutaneous electrical nerve stimulation (tens) using the same Aug. 15, 2017
-
Patent Title: Measuring the “on-skin” time of a transcutaneous electrical nerve stimulator (tens) device in order to minimize skin irritation due to excessive uninterrupted wearing of the same Jun. 13, 2017
-
Patent Title: Apparatus and method for relieving pain using transcutaneous electrical nerve stimulation May. 23, 2017
-
Patent Title: Detecting cutaneous electrode peeling using electrode-skin impedance Oct. 25, 2016
-
Patent Title: Apparatus and method for the automated measurement of sural nerve conduction velocity and amplitude Nov. 03, 2015
-
Patent Title: Estimation of f-wave times of arrival (toa) for use in the assessment of neuromuscular function Nov. 03, 2015
-
Patent Title: Transcutaneous electrical nerve stimulation (tens) device Aug. 04, 2015
-
Patent Title: Method and apparatus for quantitative nerve localization May. 26, 2015
-
Patent Title: Automated stimulus artifact removal for nerve conduction studies Apr. 21, 2015
-
Patent Title: Apparatus and method for relieving pain using transcutaneous electrical nerve stimulation Feb. 03, 2015
-
Patent Title: Transcutaneous electrical nerve stimulation device Oct. 28, 2014
-
Patent Title: Method for automated analysis of submaximal f-waves Dec. 04, 2012
-
Patent Title: Bioelectrode Oct. 16, 2012
-
Patent Title: Bioelectrode Oct. 16, 2012
-
Patent Title: Detection and classification of neuromuscular late wave activity for the assessment of neuromuscular function Dec. 13, 2011
-
Patent Title: Disposable needle electrode with identification, and alterable, connector interface Oct. 04, 2011
-
Patent Title: Method and apparatus for determining optimal neuromuscular detection sites, novel diagnostic biosensor array formed in accordance with the same, and novel method for testing a patient using the novel diagnostic biosensor array Mar. 29, 2011
-
Patent Title: Disposable, multi-purpose cardiovascular autonomic neuropathy testing device Mar. 22, 2011
-
Patent Title: Motor unit number estimation (mune) for the assessment of neuromuscular function Dec. 07, 2010
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to NURO
Recent picks made for NURO stock on CNBC
ETFs with the largest estimated holdings in NURO
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $NURO stock a Buy, Sell, or Hold?
- What is the price target for $NURO stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $NURO stock?
- Who owns the most shares of $NURO stock?
- What funds own $NURO stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view NURO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.